4//SEC Filing
El-Gabry Ehab 4
Accession 0001104659-23-026083
CIK 0001711933other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:02 PM ET
Size
7.4 KB
Accession
0001104659-23-026083
Insider Transaction Report
Form 4
El-Gabry Ehab
Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-23+16,250→ 16,250 total - Award
Employee Stock Option (Right to Buy)
2023-02-23+32,500→ 32,500 totalExercise: $12.30Exp: 2033-02-23→ Common Stock (32,500 underlying)
Footnotes (3)
- [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on the first anniversary of the grant date and on each anniversary thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
- [F3]The options shall vest as follows: twenty-five percent (25%) shall vest on the first anniversary of the grant date with the remainder vesting in 36 equal monthly installments beginning on March 23, 2024.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001923169
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:02 PM ET
- Size
- 7.4 KB